Skip Nav Destination
Issues
1 October 1983
ISSN 0022-1767
EISSN 1550-6606
In this Issue
COMMUNICATIONS
Establishment of human cell lines constitutively producing immune interferon: transformation of normal T cells by a human retrovirus.
J Immunol (1983) 131 (4): 1611–1612.
In vivo protection against Leishmania mexicana mediated by monoclonal antibodies.
J Immunol (1983) 131 (4): 1616–1618.
Dw/LD associated molecular polymorphism of DR4 beta-chains: intramolecular localization of polymorphic sites.
J Immunol (1983) 131 (4): 1622–1625.
Differential effects of intact subunits and nicked fragments of concanavalin A on immune functions in vitro and in vivo.
J Immunol (1983) 131 (4): 1626–1628.
ARTICLES
The influence of methotrexate and thymidine on the human natural killer cell function in vitro.
J Immunol (1983) 131 (4): 1619–1621.
Frequency analysis of functional immunoglobulin C and V gene expression in murine B cells at various ages.
J Immunol (1983) 131 (4): 1629–1634.
Recognition of influenza-infected cells by cytolytic T lymphocyte clones: determinant selection by class I restriction elements.
J Immunol (1983) 131 (4): 1635–1640.
Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
J Immunol (1983) 131 (4): 1641–1645.
Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.
J Immunol (1983) 131 (4): 1650–1655.
An IL 2-secreting T cell hybridoma that responds to a self class I histocompatibility antigen in the H-2D region.
J Immunol (1983) 131 (4): 1656–1662.
A comparison of the neonatal tolerance-inducing capacities of H-2 class I and class II antigens.
J Immunol (1983) 131 (4): 1670–1675.
The cellular mechanism of maintenance of neonatally induced tolerance to H-2 class I antigens.
J Immunol (1983) 131 (4): 1676–1682.
Clonal abortion of bone marrow T cell precursors: T cells acquire specific antigen reactivity prethymically.
J Immunol (1983) 131 (4): 1688–1692.
Differentiation of B lineage cells from liver of neonatal mice: generation of immunoglobulin isotype diversity in vitro.
J Immunol (1983) 131 (4): 1693–1697.
Influence of lymphokines on the anti-TNP-Ficoll response of normal and X-linked B lymphocyte-defective mice.
J Immunol (1983) 131 (4): 1698–1701.
T cell proliferative responses to a mitogen derived from Mycoplasma arthritidis are controlled by the accessory cell.
J Immunol (1983) 131 (4): 1702–1706.
Accessory cells in immune suppression. I. Role of I-A+ accessory cells in effector phase idiotype-specific suppression of myeloma function.
J Immunol (1983) 131 (4): 1728–1733.
Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
J Immunol (1983) 131 (4): 1734–1741.
Blockade of NK cell lysis is a property of monoclonal antibodies that bind to distinct regions of T-200.
J Immunol (1983) 131 (4): 1742–1747.
Allergic contact dermatitis induced by intratracheal administration of hapten.
J Immunol (1983) 131 (4): 1748–1753.
Generation and characterization of monoclonal antibodies reactive with human B lymphocytes.
J Immunol (1983) 131 (4): 1754–1761.
Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate.
J Immunol (1983) 131 (4): 1762–1764.
Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns.
J Immunol (1983) 131 (4): 1765–1770.
Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.
J Immunol (1983) 131 (4): 1771–1775.
Differential production of deoxyadenosine by human T and B lymphoblasts.
J Immunol (1983) 131 (4): 1776–1779.
Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).
J Immunol (1983) 131 (4): 1780–1783.
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
J Immunol (1983) 131 (4): 1789–1796.
Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
J Immunol (1983) 131 (4): 1797–1801.
Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.
J Immunol (1983) 131 (4): 1808–1815.
The simultaneous antagonistic effects of a T cell hybridoma product on the growth and the maturation of activated lymphocytes.
J Immunol (1983) 131 (4): 1816–1821.
Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
J Immunol (1983) 131 (4): 1822–1826.
Activation of nonspecific killer cells by interleukin 2-containing supernatants.
J Immunol (1983) 131 (4): 1827–1833.
Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1.
J Immunol (1983) 131 (4): 1834–1837.
Biochemical and physicochemical characterization of mouse B cell growth factor: a lymphokine distinct from interleukin 2.
J Immunol (1983) 131 (4): 1838–1842.
Characterization of a monoclonal antibody directed to a T cell suppressor factor.
J Immunol (1983) 131 (4): 1843–1848.
Role of interferon in human natural killer activity against target cells infected with HSV-1.
J Immunol (1983) 131 (4): 1849–1853.
Three closely linked latent rabbit IgG allotype gene products: a1, d12, e14.
J Immunol (1983) 131 (4): 1860–1864.
Structural studies of a human gamma 3 myeloma protein (Jir) bearing the allotypic marker Gm(st).
J Immunol (1983) 131 (4): 1865–1870.
The modeled structure of the IgG Gar VL region and its implications for anti-flavin and anti-DNP fine specificities.
J Immunol (1983) 131 (4): 1871–1875.
Biosynthesis, glycosylation, and in vitro translation of the human T cell antigen Leu-4.
J Immunol (1983) 131 (4): 1876–1881.
Human granulocyte surface molecules identified by murine monoclonal antibodies.
J Immunol (1983) 131 (4): 1882–1888.
Regulation of azophenylarsonate-specific repertoire expression. II. Fine specificity and isotype heterogeneity of anti-arsonate antibodies.
J Immunol (1983) 131 (4): 1889–1894.
Ia antigen: a murine B lymphocyte receptor for transformed cell induction of interferon-alpha/beta.
J Immunol (1983) 131 (4): 1895–1899.
Further characterization of cooperative interactions of monoclonal antibodies.
J Immunol (1983) 131 (4): 1906–1912.
Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).
J Immunol (1983) 131 (4): 1913–1916.
Ligand-induced association of rat lymphocyte membrane proteins with the detergent-insoluble lymphocyte cytoskeletal matrix.
J Immunol (1983) 131 (4): 1917–1919.
Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).
J Immunol (1983) 131 (4): 1920–1923.
Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
J Immunol (1983) 131 (4): 1924–1929.
C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
J Immunol (1983) 131 (4): 1930–1935.
Heterogeneity of human mast cells.
E S Schulman; A Kagey-Sobotka; D W MacGlashan, Jr; N F Adkinson, Jr; S P Peters; R P Schleimer; L M Lichtenstein
J Immunol (1983) 131 (4): 1936–1941.
Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.
J Immunol (1983) 131 (4): 1949–1953.
Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme.
J Immunol (1983) 131 (4): 1954–1960.
Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
J Immunol (1983) 131 (4): 1966–1972.
Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum.
J Immunol (1983) 131 (4): 1973–1977.
Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice.
J Immunol (1983) 131 (4): 1978–1982.
Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation.
J Immunol (1983) 131 (4): 1983–1986.
Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
J Immunol (1983) 131 (4): 1987–1993.
Differential survival of Leishmania donovani amastigotes in human monocytes.
J Immunol (1983) 131 (4): 1994–1999.
Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
J Immunol (1983) 131 (4): 2000–2003.
Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.
J Immunol (1983) 131 (4): 2011–2016.
The mechanism of retrovirus suppression of human T cell proliferation in vitro.
J Immunol (1983) 131 (4): 2017–2020.
Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV.
J Immunol (1983) 131 (4): 2021–2024.
Extensive polymorphism surrounding the murine Ia A beta chain gene.
J Immunol (1983) 131 (4): 2025–2031.
Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer.
J Immunol (1983) 131 (4): 2032–2037.
Distribution and modulation of a human leukemia-associated antigen (CALLA).
J Immunol (1983) 131 (4): 2038–2045.
Secondary in vitro generation of CTL specific for MM antigen by stimulation with somatic tumor hybrid, but not with parental tumor cells.
J Immunol (1983) 131 (4): 2059–2063.
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.
J Immunol (1983) 131 (4): 2064–2068.
Anti-mu induces lymphoma in germfree congenitally athymic (nude) but not in heterozygous (nu/+) mice.
J Immunol (1983) 131 (4): 2069–2073.
Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
J Immunol (1983) 131 (4): 2074–2078.
Tumor-associated macrophages of mouse mammary tumors. II. Differential distribution of macrophages from metastatic and nonmetastatic tumors.
J Immunol (1983) 131 (4): 2079–2085.
The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
J Immunol (1983) 131 (4): 2086–2093.
LETTERS TO THE EDITOR
ERRATA
Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation
J Immunol (1983) 131 (4): 2098.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement